• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Medtronic GI Genius rolls out with next-gen hardware

Medtronic GI Genius rolls out with next-gen hardware

August 6, 2024 By Sean Whooley

Medtronic’s GI Genius intelligent endoscopy module
Medtronic’s GI Genius intelligent endoscopy module. [Image courtesy of Medtronic]
Cosmo Intelligent Medical Devices announced that it received FDA clearance for the next-generation GI Genius hardware distributed by Medtronic (NYSE: MDT) .

The latest milestone marks the sixth generation of the GI Genius hardware, which Medtronic exclusively distributes globally. The medtech giant unveiled next-generation ColonPRO software for the platform earlier this year.

Related: How Cosmo cranked up the cancer-catching AI behind Medtronic’s GI Genius ColonPro

GI Genius’ latest iteration, rolled out by Cosmo, includes the FDA-cleared ColonPRO software. This AI application helps identify potential polyps and standardize quality metric reporting during colorectal cancer screenings.

GI Genius, a computer-aided polyp detection system powered by AI, has been available in the U.S. since 2021. It was designed to redefine GI screening by assisting gastroenterologists in performing colonoscopies.

Cosmo said in a news release that the system’s enhanced AI capabilities accelerate the system toward new features. The module can host multiple AI apps, broadening its utility, through a developer program led by Cosmo with Medtronic’s commercial expertise.

Q&A: AI tips for device developers from Cosmo Intelligent Medical Devices

GI Genius also now has improved connectivity, enhanced energy efficiency and integrated hardware for more reliable real-time performance. Cosmo said the advancements came through engineering efforts using Nvidia IGX Orin and Holoscan technologies.

“The GI Genius system sets a new standard in endoscopic technology. Our continuous innovation is driven by a commitment to enhancing patient care through AI. This FDA clearance marks a significant achievement, reinforcing our leadership in the field and our dedication to providing physicians with the tools they need to deliver exceptional medical outcomes,” said Nhan Ngo Dinh, president of Cosmo Intelligent Medical Devices.

Medical Design & Outsourcing: Innovating with speed and a startup mentality: Cosmo’s Nhan Ngo Dinh and Andrea Cherubini offer lessons from their Medtronic AI project

Filed Under: 510(k), Artificial Intelligence (AI), Big Data, Business/Financial News, Featured, Food & Drug Administration (FDA), Health Technology, Imaging, Machine Learning (ML), Men's Health, Regulatory/Compliance, Software / IT, Urology Tagged With: Cosmo Intelligent Medical Devices, Cosmo Pharmaceuticals, Medtronic

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy